Total
0
Shares
Imagion Biosystems (ASX:IBX) - CEO & President, Bob Proulx - The Market Herald
CEO & President, Bob Proulx
Source: HotCopper
Market Herald logo

Find out more about this capital raise

Be the first with the news that moves the market
  • Imagion Biosystems (IBX) has entered a trading halt as it plans and executes a capital raise
  • The healthcare company will remain in the halt until November 23 or when the announcement is made, whichever occurs first
  • In early October, Imagion received Human Research Ethics Approval (HREC) for its MagSense HER2 phase one breast cancer study
  • A week later, Geoff Hollis was appointed as the company's new Chief Financial Officer, effective December 1
  • He'll replace Brian Conn, who left Imagion in August to take on another full-time CFO role
  • Shares in IBX last traded for 12.5 cents on November 17

Imagion Biosystems (IBX) has entered a trading halt as it plans and executes a capital raise.

The healthcare company will remain in the halt until November 23 or when the announcement is made, whichever occurs first.

Imagion is yet to announce how much it is aiming to raise or what it will use the funding for.

In early October, Imagion received Human Research Ethics Approval (HREC) for its MagSense HER2 phase one study for breast cancer.

MagSense uses disease-specific targeting nanoparticles and highly sensitive detectors to find tumours and other diseased cells.

According to Imagion, it doesn't use radiation, instead dispatching tiny bio-safe nanoparticles coated with tumour-targeting antibodies.

The company expects to begin the study sometime this quarter.

A week later, Geoff Hollis was appointed as the company's new Chief Financial Officer, effective December 1.

He'll replace Brian Conn, who left Imagion in August to take on another full-time CFO role.

Geoff was previously the CFO of Lifestyle Communities, where he played a key role in cash management and financing to facilitate growth, creating shareholder value, and reaching the ASX 300.

Shares in IBX last traded for 12.5 cents on November 17.

IBX by the numbers
More From The Market Herald
APM proposes to purchase 100pc of Konekt shares

" Redstone Resources (ASX:RDS) prepares for approaching capital raise

Minerals exploration company Redstone Resources (RDS) has placed its shares in a trading halt in preparation for an upcoming capital raise.